TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/26/23 17:30 | 1/24/23 | AVRO | Avrobio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 42 | 0.9100 | 0 | 46 | 6 | 778 | M | ||||||||||||||
12/28/22 19:18 | 12/23/22 | AVRO | Avrobio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 59 | 0.4132 | 0 | 142 | 24 | 732 | D | ||||||||||||||
12/28/20 19:46 | 12/24/20 | AVRO | Avrobio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 41 | 0.4132 | 0 | 100 | 20 | 590 | D | ||||||||||||||
2/14/20 19:16 | 2/12/20 | AVRO | Avrobio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S | -41 | 29.07 | 0 | -1 | 0 | 490 | D | ||||||||||||||
2/11/20 21:23 | 2/11/20 | AVRO | Avrobio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S | -1,737 | 27.57 | 0 | -63 | -11 | 492 | D | ||||||||||||||
4/9/19 16:27 | 4/5/19 | AVRO | Avrobio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S.m | -382 | 27.25 | 0 | -14 | -2 | 555 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |